Literature DB >> 23866185

Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.

Vasim Farooq1, Yvonne Vergouwe, Philippe Généreux, Christos V Bourantas, Tullio Palmerini, Adriano Caixeta, Hector M Garcìa-Garcìa, Roberto Diletti, Marie-angèle Morel, Thomas C McAndrew, Arie Pieter Kappetein, Marco Valgimigli, Stephan Windecker, Keith D Dawkins, Ewout W Steyerberg, Patrick W Serruys, Gregg W Stone.   

Abstract

OBJECTIVES: This study sought to validate the Logistic Clinical SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score in patients with non-ST-segment elevation acute coronary syndromes (ACS), in order to further legitimize its clinical application.
BACKGROUND: The Logistic Clinical SYNTAX score allows for an individualized prediction of 1-year mortality in patients undergoing contemporary percutaneous coronary intervention. It is composed of a "Core" Model (anatomical SYNTAX score, age, creatinine clearance, and left ventricular ejection fraction), and "Extended" Model (composed of an additional 6 clinical variables), and has previously been cross validated in 7 contemporary stent trials (>6,000 patients).
METHODS: One-year all-cause death was analyzed in 2,627 patients undergoing percutaneous coronary intervention from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Mortality predictions from the Core and Extended Models were studied with respect to discrimination, that is, separation of those with and without 1-year all-cause death (assessed by the concordance [C] statistic), and calibration, that is, agreement between observed and predicted outcomes (assessed with validation plots). Decision curve analyses, which weight the harms (false positives) against benefits (true positives) of using a risk score to make mortality predictions, were undertaken to assess clinical usefulness.
RESULTS: In the ACUITY trial, the median SYNTAX score was 9.0 (interquartile range 5.0 to 16.0); approximately 40% of patients had 3-vessel disease, 29% diabetes, and 85% underwent drug-eluting stent implantation. Validation plots confirmed agreement between observed and predicted mortality. The Core and Extended Models demonstrated substantial improvements in the discriminative ability for 1-year all-cause death compared with the anatomical SYNTAX score in isolation (C-statistics: SYNTAX score: 0.64, 95% confidence interval [CI]: 0.56 to 0.71; Core Model: 0.74, 95% CI: 0.66 to 0.79; Extended Model: 0.77, 95% CI: 0.70 to 0.83). Decision curve analyses confirmed the increasing ability to correctly identify patients who would die at 1 year with the Extended Model versus the Core Model versus the anatomical SYNTAX score, over a wide range of thresholds for mortality risk predictions.
CONCLUSIONS: Compared to the anatomical SYNTAX score alone, the Core and Extended Models of the Logistic Clinical SYNTAX score more accurately predicted individual 1-year mortality in patients presenting with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention. These findings support the clinical application of the Logistic Clinical SYNTAX score.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACS; BMS; CrCl; DES; IQR; LVEF; PCI; PVD; SYNTAX score; acute coronary syndrome; acute coronary syndromes; bare-metal stent(s); creatinine clearance; drug-eluting stent(s); drug-eluting stents; interquartile range(s); left ventricular ejection fraction; mortality; percutaneous coronary intervention; peripheral vascular disease; predictions; validation

Mesh:

Year:  2013        PMID: 23866185     DOI: 10.1016/j.jcin.2013.04.004

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

1.  Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.

Authors:  Yavuz Karabağ; Metin Çağdaş; Ibrahim Rencuzogullari; Süleyman Karakoyun; İnanç Artaç; Doğan İliş; Mahmut Yesin; Mesut Öterkus; Tayyar Gokdeniz; Cengiz Burak; Ibrahim Halil Tanboğa
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-14       Impact factor: 2.357

2.  Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.

Authors:  Roberto Martín-Reyes; Juan Antonio Franco-Peláez; Óscar Lorenzo; María Luisa González-Casaus; Ana María Pello; Álvaro Aceña; Rocío Carda; José Luis Martín-Ventura; Luis Blanco-Colio; María Luisa Martín-Mariscal; Juan Martínez-Milla; Ricardo Villa-Bellosta; Antonio Piñero; Felipe Navarro; Jesús Egido; José Tuñón
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

3.  Incremental Prognostic Value of the Incorporation of Clinical Data Into Coronary Anatomy Data in Acute Coronary Syndromes: SYNTAX-GRACE Score.

Authors:  Mateus Dos Santos Viana; Fernanda Lopes; Antonio Mauricio Dos Santos Cerqueira Junior; Jessica Gonzalez Suerdieck; André Barcelos da Silva; Ana Clara Barcelos da Silva; Thiago Menezes Barbosa de Souza; Manuela Campelo Carvalhal; Marcia Maria Noya Rabelo; Luis Claudio Lemos Correia
Journal:  Arq Bras Cardiol       Date:  2017-11-13       Impact factor: 2.000

4.  Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.

Authors:  Xiao-Feng Wang; Ming Zhao; Fei Liu; Guo-Rong Sun
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

5.  Usefulness of the SYNTAX Score II to Predict In-Hospital and Long-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Betul Balaban Kocas; Gokhan Cetinkal; Cuneyt Kocas; Sukru Arslan; Okay Abaci; Yalcin Dalgic; Ozgur Selim Ser; Servet Batit; Ahmet Yildiz; Sait Mesut Dogan
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28

6.  Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents.

Authors:  Ji-Qiang He; Xian-Peng Yu; Cheng Peng; Quan Li; Ya-Wei Luo; Yue-Chun Gao; Xiao-Ling Zhang; Chang-Yan Wu; Hua Zhao; Yu-Chen Zhang; Jing-Hua Liu; Shu-Zheng Lyu; Fang Chen
Journal:  Chin Med J (Engl)       Date:  2015-08-20       Impact factor: 2.628

7.  Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.

Authors:  Slayman Obeid; Antonio H Frangieh; Lorenz Räber; Nooraldaem Yousif; Thomas Gilhofer; Kyohei Yamaji; Milosz Jaguszewski; Soheila Aghlmandi; James Adams; Yannik Bockhorn; Christian Templin; Barbara E Stähli; Peter Jüni; Nicolas Rodondi; François Mach; Marco Roffi; Stephan Windecker; Willibald Maier; Fabian Nietlispach; Christian M Matter; Roland Klingenberg; Thomas F Lüscher
Journal:  Cardiol Res Pract       Date:  2018-09-25       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.